TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

National Advertising Division Will Refer BridgeBio Pharma to Government Agencies for Failure to Participate in Inquiry

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Globe Newswire
National Advertising Division Will Refer BridgeBio Pharma to Government Agencies for Failure to Participate in Inquiry

The National Advertising Division will refer BridgeBio Pharma to government agencies after the company failed to participate in an NAD inquiry regarding claims about its Attruby medication's superiority over Pfizer's Vyndamax.

Insights
BBIO   negative

Company declined to participate in NAD inquiry and will be referred to government agencies for potential enforcement action